logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > Risedronate Sodium CAS 115436-72-1 for Improved Bone Density

Risedronate Sodium CAS 115436-72-1 for Improved Bone Density

Product Details

Place of Origin: Chinan

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 115436-72-1

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:

CAS 115436-72-1 Risedronate Sodium

,

Risedronate Sodium

,

CAS 115436-72-1

Appearance::
Fine White To Off-white Crystalline Powder
CAS NO::
115436-72-1
Molecular Formula::
C7H10NNaO7P2
Molecular Weight::
305.09400
EINECS NO::
658-043-1
MDL NO::
MFCD01706268
Appearance::
Fine White To Off-white Crystalline Powder
CAS NO::
115436-72-1
Molecular Formula::
C7H10NNaO7P2
Molecular Weight::
305.09400
EINECS NO::
658-043-1
MDL NO::
MFCD01706268
Risedronate Sodium CAS 115436-72-1 for Improved Bone Density

Product Description:

Product Name: Risedronate Sodium CAS NO: 115436-72-1                                             

                    

Synonyms:

3-Pyridyl-1-hydroxyethylidene-1,1-biphosphonic acid sodium salt;

Phosphonic acid, P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-, sodium salt (1:1);

sodium hydrogen-1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethylphosphonate;

 

Chemical & Physical Properties:

Appearance: Fine white to off-white crystalline powder

Assay :≥98.0%

Boiling Point: 692.3℃ at 760 mmHg

Flash Point: 372.5℃

Vapor Pressure: 4.03E-20mmHg at 25℃

Storage Temp.: Store at RT

Solubility: H2O: soluble5mg/mL, clear (warmed)


Safety Information:

Hazard Declaration: H302 + H312 + H332

Caution Statement: P280

Symbol: GHS07

Signal Word: Warning


Risedronic acid (INN) often used as its sodium salt risedronate sodium (USAN) is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone. It is produced and marketed by Warner Chilcott, Sanofi-Aventis, and in Japan by Takeda under the trade names Actonel, Atelvia, and Benet. It is also available in a preparation that includes a calcium carbonate supplement, as Actonel with Calcium. Risedronic Acid is a pyridinyl biphosphonate bone resorption inhibitor. Risedronate sodium is a pyridinyl biphosphonate which inhibits osteoclast-mediated bone resorption.Target: Risedronate sodium, which was promoted in Croatia a few months ago, is the latest (III) generation of bisphosphonates, the most efficient anti-resorption drugs that inhibit osteoclast-mediated bone resorption and change the bone metabolism. Risedronate sodium is hence the first line of bisphosphonates for the reduction of vertebral and non-vertebral fracture risks in postmenopausal women with osteoporosis or those with a high risk of osteoporosis.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.